Literature DB >> 19589780

Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation.

Lassad Oussaief1, Aurélie Hippocrate, Vanessa Ramirez, Aurore Rampanou, Wei Zhang, David Meyers, Philip Cole, Ridha Khelifa, Irène Joab.   

Abstract

Epstein-Barr virus, a ubiquitous human herpesvirus, is associated with the development of carcinomas and lymphomas. We previously showed that transforming growth factor beta1 (TGF-beta1) mediated the virus to enter the lytic cycle, which is triggered by expression of Z Epstein-Barr virus replication activator (ZEBRA), through the ERK 1/2 MAPK signaling pathway. We report here that Akt, activated downstream from ERK 1/2, was required for TGF-beta1-induced ZEBRA expression and enabled Smad3, a mediator of TGF-beta1 signaling, to be acetylated by direct interaction with the co-activator CREB-binding protein and then to regulate TGF-beta1-induced ZEBRA expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589780      PMCID: PMC2781985          DOI: 10.1074/jbc.M109.036483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling.

Authors:  H Gruffat; E Manet; A Sergeant
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

4.  Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.

Authors:  H Fahmi; C Cochet; Z Hmama; P Opolon; I Joab
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF.

Authors:  O D Lau; T K Kundu; R E Soccio; S Ait-Si-Ali; E M Khalil; A Vassilev; A P Wolffe; Y Nakatani; R G Roeder; P A Cole
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

6.  Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).

Authors:  James F Callahan; Joelle L Burgess; James A Fornwald; Laramie M Gaster; John D Harling; Frank P Harrington; Jag Heer; Chet Kwon; Ruth Lehr; A Mathur; Barbara A Olson; Joseph Weinstock; Nicholas J Laping
Journal:  J Med Chem       Date:  2002-02-28       Impact factor: 7.446

7.  Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins.

Authors:  Chih-Lung Liang; Jo-Lin Chen; Yun-Pung Paul Hsu; Jonathan T Ou; Yu-Sun Chang
Journal:  J Biol Chem       Date:  2002-04-23       Impact factor: 5.157

8.  Epstein-Barr virus upregulates phosphorylated heat shock protein 27 kDa in carcinoma cells using the phosphoinositide 3-kinase/Akt pathway.

Authors:  Yuki Fukagawa; Jun Nishikawa; Yasuhiro Kuramitsu; Dai Iwakiri; Kenzo Takada; Shousuke Imai; Masaaki Satake; Takeshi Okamoto; Masanori Fujimoto; Kiwamu Okita; Kazuyuki Nakamura; Isao Sakaida
Journal:  Electrophoresis       Date:  2008-08       Impact factor: 3.535

9.  Heterogeneous Epstein-Barr virus latent gene expression in AIDS-associated lymphomas and in type I Burkitt's lymphoma cell lines.

Authors:  R Touitou; H Arbach; C Cochet; J Feuillard; A Martin; M Raphaël; I Joab
Journal:  J Gen Virol       Date:  2003-04       Impact factor: 3.891

10.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Authors:  Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

View more
  13 in total

1.  Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

Authors:  Tawin Iempridee; Shreyasi Das; Iris Xu; Janet E Mertz
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 2.  Ghrelin O-acyltransferase assays and inhibition.

Authors:  Martin S Taylor; Yousang Hwang; Po-Yuan Hsiao; Jef D Boeke; Philip A Cole
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 3.  The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.

Authors:  XueQiao Liu; Jeffrey I Cohen
Journal:  Virology       Date:  2015-03-20       Impact factor: 3.616

4.  NF-kappaB-mediated modulation of inducible nitric oxide synthase activity controls induction of the Epstein-Barr virus productive cycle by transforming growth factor beta 1.

Authors:  Lassad Oussaief; Vanessa Ramírez; Aurélie Hippocrate; Hratch Arbach; Chantal Cochet; Alexis Proust; Martine Raphaël; Ridha Khelifa; Irène Joab
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

5.  TGF-β1 mediates the effects of aspirin on colonic tumor cell proliferation and apoptosis.

Authors:  Yuyi Wang; Chi Du; Nan Zhang; Mei Li; Yanyang Liu; Maoyuan Zhao; Feng Wang; Feng Luo
Journal:  Oncol Lett       Date:  2018-02-14       Impact factor: 2.967

6.  EBV reactivation as a target of luteolin to repress NPC tumorigenesis.

Authors:  Chung-Chun Wu; Chih-Yeu Fang; Hui-Yu Hsu; Hsin-Ying Chuang; Yu-Jhen Cheng; Yen-Ju Chen; Sheng-Ping Chou; Sheng-Yen Huang; Su-Fang Lin; Yao Chang; Ching-Hwa Tsai; Jen-Yang Chen
Journal:  Oncotarget       Date:  2016-04-05

7.  Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies.

Authors:  Chung King Choi; Dona N Ho; Kwai Fung Hui; Richard Y Kao; Alan K S Chiang
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

8.  Systems biology approach reveals genome to phenome correlation in type 2 diabetes.

Authors:  Priyanka Jain; Saurabh Vig; Malabika Datta; Dinesh Jindel; Ashok Kumar Mathur; Sandeep Kumar Mathur; Abhay Sharma
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

9.  Membrane type 1-matrix metalloproteinase/Akt signaling axis modulates TNF-α-induced procoagulant activity and apoptosis in endothelial cells.

Authors:  Hiroshi Ohkawara; Toshiyuki Ishibashi; Koichi Sugimoto; Kazuhiko Ikeda; Kazuei Ogawa; Yasuchika Takeishi
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

Review 10.  Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.

Authors:  Jean-Marie Carpier; Carrie L Lucas
Journal:  Front Immunol       Date:  2018-01-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.